Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05081375 · ClinicalTrials.gov registry record · Phase 4
Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
A Phase 4 study, sponsored by Valleywise Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT05081375 is a Phase 4 study that was terminated before completion, run by Valleywise Health. The registered enrollment target is 6 participants.
The verdict
NCT05081375, a Phase 4 study, was terminated before completion, sponsored by Valleywise Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
All trauma patients receive Lovenox or other prophylactic medication to prevent deep vein clots from forming. For the trauma patients with orthopedic injuries requiring surgery there is controversy over safety and efficacy when prophylaxis is started preoperatively vs postoperatively. This study is to evaluate both approaches for safety in terms of bleeding events during and 24 hours after surgery as well as preventing deep vein clot formation. This will be a randomized double blinded study using Lovenox or placebo as the medications given preoperatively. Postoperative Lovenox will be given to both groups per routine regime.
Interventions
- DRUG Enoxaparin Injectable Product
- DRUG Sodium chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2023-11-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05081375
The ClinicalTrials.gov registry entry for NCT05081375 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valleywise Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enoxaparin Injectable Product is the first listed.
NCT05081375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05081375 about?
NCT05081375 is a clinical study titled "Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures". All trauma patients receive Lovenox or other prophylactic medication to prevent deep vein clots from forming. For the trauma patients with orthopedic injuries requiring surgery there is controversy over safety and efficacy when prophylaxis is started preoperatively vs postoperatively. This study is ...
What is the current status of trial NCT05081375?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2019-12-16. Estimated completion is 2023-11-02.
What interventions are being tested in trial NCT05081375?
The interventions under investigation include: Enoxaparin Injectable Product (DRUG), Sodium chloride (DRUG).
Who is sponsoring clinical trial NCT05081375?
This trial is sponsored by Valleywise Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.